SMS for Life (B): Living the implementation challenges of a successful pilot project
After successfully completing the roll-out of the SMS for Life project in three health districts in Tanzania, Jim Barrington, former group CIO of Novartis and Project Director for SMS for Life with Roll-Back Malaria, faces a number a challenges for implementing the project full scale in Tanzania as well as having other African countries (including Kenya, Ghana, The Democratic Republic of the Congo) adopt the SMS for Life project approach. This case covers the implementation efforts of Jim in these countries as well as new challenges he is facing as competitors in the pharmaceutical industry learn about the project and its use in managing the supply chains for the private distribution of drugs in Africa. In addition, new interest by NGOs is developing on “drug access” to stock in African countries as well as launching new funding formulas for the distribution of malaria and other drugs on a private and public basis. Finally, companies that help consumers distinguish between fake and genuine medicines and drugs are using SMS for Life type capabilities as well. In the winter of 2011, Jim Barrington faces important questions: 1) Where should he continue to focus his time and energy? 2) What can Novartis as a healthcare company do to compete with SMS for Life capabilities developing in both the public and private distribution of drugs in Africa? 3) What roles should business and IT leaders in Novartis play in exploiting what started as a pro bono “corporate social responsibility” pilot project in the public sector to achieve competitive value in Novartis businesses? 4) What other strategies like SMS for Life could Novartis pursue to manage “information about products” as new and emerging services in the healthcare industry?
There are three learning objectives and ways to teach this case: 1) to discuss how to lead and manage a successful pilot project into a full scale roll-out in multiple countries with different stakeholders and funding approaches; 2) to understand how a project launched as a corporate social responsibility effort develops competitive value in the private sector and what the opportunities and trade-offs are for both Novartis and its competitors? And 3) to address the challenges of being involved in emerging patient-centric and information-based business initiatives for companies whose focus and operating cultures have been primarily product-based in the healthcare industry.
Novartis, Healthcare, Pharmaceuticals
April 2010-February 2011
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
Nespresso, the global leading brand in portioned coffee, is facing an existential threat. The company’s current market base, which consists primari...
By 2026, it's predicted that over 80% of organizations will have employed generative artificial intelligence (GenAI) in some capacity, up from less...
Choosing a CEO is a crucial decision for any company, but it becomes particularly complex in family businesses. This difficulty stems from the need...
Family businesses often have not only financial wealth but also nonfinancial values that make them different from nonfamily companies. For instance...
Leadership presence (LP) is widely acknowledged as a foundation of effective leadership. Historically, LP has been conceptualized as a collection o...
With organizations of all sorts facing increased urgency and unpredictability, being able to ask smart questions has become key. But unlike lawyers...
No company can grasp the potential of AI until it has set up a data-driven culture enabling employees to create value from the insights that emerge...
In a world where agility and global foresight are crucial for business survival and growth, the FUCHS case presents a compelling narrative of trans...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Harvard Business Review May-June 2024, vol. 102, issue 3
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications